If you’re a fan of the heavyweight boxers of the 1970s, then you know all about “The Fight.” That was the epic first battle between all-time greats Muhammad Ali and Joe Frazier, which Frazier won by unanimous decision in 15 rounds on March 8, 1971. Ali’s ringside physician, Dr. Ferdie Pacheco, has called it the greatest fight Ali ever lost. #-ad_banner-#Well, today, more than 40 years later, there’s a highly touted new growth stock that’s sort of like that. It might be called the greatest growth stock nobody should own. And… Read More
If you’re a fan of the heavyweight boxers of the 1970s, then you know all about “The Fight.” That was the epic first battle between all-time greats Muhammad Ali and Joe Frazier, which Frazier won by unanimous decision in 15 rounds on March 8, 1971. Ali’s ringside physician, Dr. Ferdie Pacheco, has called it the greatest fight Ali ever lost. #-ad_banner-#Well, today, more than 40 years later, there’s a highly touted new growth stock that’s sort of like that. It might be called the greatest growth stock nobody should own. And it has been impressive, more than doubling already in the six weeks or so since its initial public offering (IPO) on August 1. The IPO raised nearly $900 million, making it the largest ever by an Israeli company. But despite all the hype, analysts at Deutsche Bank recently showed some sense and downgraded the stock from “buy” to “hold” in the wake of its massive gains. Frankly, though, Deutsche Bank would have better served investors by recommending they sell Mobileye N.V. (NYSE: MBLY), which makes advanced driver assistance systems for the auto… Read More